Evidence map›Paper›PMID 40242428›Full record

ArticleSurgical case reports2025

Gastric Epithelioid Mesenchymal Tumor with the

Nao Yoshizawa, Hirokazu Yamaguchi, Taichiro Yoshimoto, Koji Uraushihara, Akihiko Yoshida

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nao YoshizawaDepartment of Gastroenterological Surgery, Showa General Hospital, Kodaira, Tokyo, Japan.
Hirokazu YamaguchiDepartment of Gastroenterological Surgery, Showa General Hospital, Kodaira, Tokyo, Japan.
Taichiro YoshimotoDepartment of Diagnostic Pathology, Showa General Hospital, Kodaira, Tokyo, Japan.
Koji UraushiharaDepartment of Gastroenterology, Showa General Hospital, Kodaira, Tokyo, Japan.
Akihiko YoshidaDepartment of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn recent years, new molecularly defined tumor groups have been reported among tumors previously considered unclassifiable. Among them, gene fusions involving the CREB family of transcription factors, including cAMP-responsive element modulator ( CASE PRESENTATION: A 58-year-old man with epigastric pain underwent esophagogastroduodenoscopy, which revealed a submucosal tumor, 40 × 30 mm in size, at the greater curvature of the upper gastric body. Surgical resection was scheduled because of easy bleeding from the tumor and because biopsy could not establish a diagnosis. The tumor was clinically considered benign because there was no significant accumulation on positron emission tomography scans. Therefore, we performed a local resection of the stomach. Histologically, the tumor consisted of a proliferation of keratin-positive, relatively uniform epithelioid cells arranged in sheets, with a scattering of lymphoid follicles in the surrounding area. Based on a pathology consultation, the tumor was diagnosed as a mesenchymal tumor with

conclusionWe experienced a gastric epithelioid mesenchymal tumor with

Indexed as

EWSR1::CREM gene fusionEWSR1/FUS::CREB fusiongastric mesenchymal tumor

Identifiers

PMID40242428
PMCPMC11999874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.